CS Diagnostics Corp. (CSDX)

OTCMKTS · Delayed Price · Currency is USD
0.1100
0.00 (0.00%)
Aug 25, 2025, 9:30 AM EDT
Market Cap12.75M
Revenue (ttm)128.07K
Net Income (ttm)24.26K
Shares Out137.34M
EPS (ttm)0.00
PE Ratio525.27
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume25,055
Open0.1100
Previous Close0.1100
Day's Range0.1100 - 0.1100
52-Week Range0.0360 - 5.6400
Beta-21.65
RSI55.44
Earnings Daten/a

About CS Diagnostics

CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant product; and CS-Protect Hydrogel, a tissue spacer gel for use in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Neuss, Germany. [Read more]

Sector Healthcare
Founded 1996
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol CSDX
Full Company Profile

Financial Performance

Financial Statements

News

CS Diagnostics Corp. Submitted Final Form-10 Registration Statement Draft to the processing team for preparation of Edgardization and filing with the U.S. Securities and Exchange Commission ("SEC")

NEUSS, GERMANY AND CHEYENNE, WY / ACCESS Newswire / July 16, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) is pleased to announce that it has successfully submitted the final draft of Form F-10 registratio...

6 weeks ago - Accesswire

CS Diagnostics Corp. to Present at the Small Cap Growth Virtual Investor Conference June 26th

DUBAI, United Arab Emirates, June 24, 2025 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX), based in Germany and USA and focused on innovation in Healthcare, today announced that Thomas Fahrhoe...

2 months ago - GlobeNewsWire

CS Diagnostics Corp. CSDX to Present at the Small Cap Growth Virtual Investor Conference on June 26, 2025 at 12:30pm EDT

NEUSS, DE / ACCESS Newswire / June 18, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) a global leader in innovative healthcare solutions announced its participation in the Small Cap Growth Virtual Investor ...

2 months ago - Accesswire

CS Diagnostics Corp. is Entering into a $5 Million Loan Agreement with SAN ART CAPITAL SAS

CHEYENNE, WY / ACCESS Newswire / April 15, 2025 / Neuss, Germany: CS Diagnostics Corp. is pleased to announce that it has received a Letter of Intent from SAN ART CAPITAL SAS, a leading advisory and i...

4 months ago - Accesswire

OTCQB-CSDX Appoints Lachman Consultants for CS-Protect Hydrogel FDA Approval

CS DIAGNOSTICS CORP. ANNOUNCES THE APPOINTMENT OF FDA CONSULTANTS Innovative tissue spacer technology for cancer radiology treatments CHEYENNE, WY / ACCESS Newswire / March 12, 2025 / CS Diagnostics C...

6 months ago - Accesswire

CS Diagnostics Corp. Announces U.S. Launch of MEDUSA

NEUSS, Germany--(BUSINESS WIRE)--CS Diagnostics Corp. Announces U.S. Launch of MEDUSA.

7 months ago - Business Wire